TechConnect


Longitude Capital Closes $385 Million Life Sciences Fund

October 12, 2012 07:56 AM EST By: Jennifer Rocha

In 2008, the firm's first Life Sciences Fund raised $325 Million

Over the last four years, Longitude has invested in close to 20 companies with its first Life Sciences Fund, including Aptus Endosystems, Civitas Therapeutics, and NxStage Medical.  This latest Fund will focus on investments in drug development and medical technology companies that are at the mid stage to commercialization stage.  Longitude Capital has offices in Menlo Park, CA and Greenwich, CT.

 

Subscribe to our mailing list, and we'll keep you posted of the latest developments.

RSS feed of TechConnect News™ RSS feed of TechConnect News™

Annual Meeting

TechConnect World 2014
Washington, DC, June 15-18, 2014
 

Event Spotlight

NISS 2014
Washington, DC, June 15-18, 2014
NSBIRC 2014
Washington, DC, June 16-18, 2014
APCE 2014
Honolulu, Hawaii, September 15-17, 2014
DES
Austin, TX, November 11-14, 2014


© TechConnect. All Rights Reserved. Disclaimer
Terms of Use | Privacy Policy | Contact Us | Site Map